Sofosbuvir/ledipasvir plus ribavirin achieves high SVR12 in genotype‐3 patients with compensated cirrhosis and similar to sofosbuvir plus daclatasvir: a multicentre real life cohort

Simple item page
UDC.coleccionInvestigaciónes_ES
UDC.conferenceTitle67th Annual Meeting of the American Association for the Study of Liver Diseases: the liver meeting 2016es_ES
UDC.grupoInvViroloxía Clínica (INIBIC)es_ES
UDC.institutoCentroINIBIC - Instituto de Investigacións Biomédicas de A Coruñaes_ES
UDC.issueSpecial issue 1es_ES
UDC.journalTitleHepatologyes_ES
UDC.startPage464Aes_ES
UDC.volume64es_ES
dc.contributor.authorRiveiro-Barciela, M.
dc.contributor.authorAlonso, Sonia
dc.contributor.authorFernández, Inmaculada
dc.contributor.authorRincón, D.
dc.contributor.authorReal, Yolanda
dc.contributor.authorCrespo, Javier
dc.contributor.authorGea, F.
dc.contributor.authorOlveira, Antonio
dc.contributor.authorCalleja-Panero, José Luis
dc.contributor.authorPolo Lorduy, B.
dc.contributor.authorCarrión, José A.
dc.contributor.authorArenas, Juan
dc.contributor.authorDevesa, M.J.
dc.contributor.authorBaliellas, Carme
dc.contributor.authorCastro-Iglesias, Ángeles
dc.contributor.authorRomero-Gómez, Manuel
dc.contributor.authorGranados, R.
dc.contributor.authorPascasio Acevedo, Juan Manuel
dc.contributor.authorForns, Xavier
dc.contributor.authorTurnes Vázquez, Juan
dc.contributor.authorMontero, J.L.
dc.contributor.authorEsteban, R.
dc.contributor.authorFernández-Rodríguez, Conrado M.
dc.date.accessioned2019-02-15T10:20:27Z
dc.date.available2019-02-15T10:20:27Z
dc.date.issued2016-10
dc.descriptionPoster abstractes_ES
dc.identifier.citationRiveiro-Barcela M, Alonso S, Fernández I, et al. Sofosbuvir/ledipasvir plus ribavirin achieves high SVR12 in genotype‐3 patients with compensated cirrhosis and similar to sofosbuvir plus daclatasvir: a multicentre real life cohort. En: The 67th Annual Meeting of the American Association for the Study of Liver Diseases: the Liver Meeting 2016; 2016 Nov 11-15; Boston, Massachusetts. Hoboken, NJ: John Wiley & Sons; 2016. p. 464A (Heaptology. 2016; 64 Special issue 1)es_ES
dc.identifier.issn0270-9139
dc.identifier.urihttp://hdl.handle.net/2183/21786
dc.language.isoenges_ES
dc.publisherWileyes_ES
dc.relation.urihttps://aasldpubs.onlinelibrary.wiley.com/doi/full/10.1002/hep.28798es_ES
dc.rightsThis is the peer reviewed version of the article which has been published in final form at Hepatology. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for self-archivinges_ES
dc.rights.accessRightsopen accesses_ES
dc.titleSofosbuvir/ledipasvir plus ribavirin achieves high SVR12 in genotype‐3 patients with compensated cirrhosis and similar to sofosbuvir plus daclatasvir: a multicentre real life cohortes_ES
dc.typeconference outputes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationf6aa3126-5f84-436d-9da4-f62438f45c9e
relation.isAuthorOfPublication.latestForDiscoveryf6aa3126-5f84-436d-9da4-f62438f45c9e

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Riveiro_Sofosbuvir.pdf
Size:
124.08 KB
Format:
Adobe Portable Document Format
Description:
Download

Collections

Investigación (FCS)